Case study:
Smart logic PA in action

Our smart logic prior authorization (PA) helps ensure GLP-1s approved to type 2 diabetes are covered appropriately and not for off-label use for weight management – with minimal disruption to patients who have diabetes. Watch our case study video to see how it works and how it helped save one employer $7.5M.